Combination Therapies: Recipes for Success
Putting two drugs together in one formulation can sometimes achieve better results than either agent can by itself.
What clinicians should know about ocular allergies
Taking a fresh look at up-to-the-minute treatment modalities for managing patients’ symptoms
Wintering with Ocular Allergies
A look at the attributes of perennial allergy and therapies designed to combat the chronic inflammation it engenders.
Working Magic with Pharmacokinetics
How increasing the absorption, bioavailability and/or retention of a drug can result in better efficacy without greater side effects.
Challenges faced in clinical trials for chronic allergic conjunctivitis
Among chronic diseases, allergy is documented as the fifth leading group affecting 50 million Americans.
‘Tis the season to be red-eyed
It’s prime allergy season: Here’s a primer on what to advise patients with an itch to ditch.
ARVO 2015 meeting finds connections in innovative drug delivery, therapies
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
Delivering a Rocky Mountain ARVO
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
Ocular Therapeutix™ Begins Enrollment in Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis
Phase 3 Allergy Program Establishes Clinical Indication Expansion Strategy of DEXTENZA™
The Secrets of Ocular Microbiomes
The placid ocular surface is actually teeming with life that might
hold the secret to treating ophthalmic disease.